Biomedical research laboratories occasionally undertake a software
development project to solve a problem the laboratory faces. These software
packages sometimes evolve into a well-designed system that can be easily
extended and that is useful to a much broader community other than the
members of the originating laboratory. The goal of this PA is to support the
continued development, maintenance, testing and evaluation of existing
software. The proposed work should apply best practices and proven methods
for software design, construction and implementation to extend the
applicability of existing bioinformatics/computational biology software to a
broader biomedical research community.
Find Funding Opportunities
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Expiration Date: Friday, February 25, 2005 NOFO Number: PA-02-141 Release Date: Friday, July 26, 2002 Notice Type: PA
Expiration Date: Sunday, July 31, 2005 NOFO Number: PAR-02-139 Release Date: Friday, July 26, 2002 Notice Type: PAR
Recent discoveries across a broad range of research areas in the
neurosciences offer promising opportunities for treatment of neurological
disorders. As part of its mission to reduce the burden of neurological
disease, NINDS is committed to encouraging the "translation" of these
discoveries into new treatments. The goal of this PA is to implement a
program of cooperative agreements that will support milestone-driven projects
focused on the identification and pre-clinical testing of new therapeutics.
The program will facilitate the effective review and research administration
of translational research projects and will accelerate the translation of
discoveries in basic research to treatment in the clinic.
Expiration Date: Sunday, July 31, 2005 NOFO Number: PAR-02-140 Release Date: Friday, July 26, 2002 Notice Type: PAR
Recent discoveries across a broad range of research areas in the neurosciences
offer promising opportunities for improved therapies for neurological disorders.
As part of its mission to reduce the burden of neurological disease, NINDS is
committed to encouraging the "translation" of these basic discoveries into new
treatments. The goal of this PA is to announce a career development opportunity
for new investigators to build a program of translational research in
neurological disorders under the guidance of an experienced mentor.
Expiration Date: Thursday, March 30, 2006 NOFO Number: PA-02-136 Release Date: Thursday, July 25, 2002 Notice Type: PA
The National Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS), the National Institute on Aging (NIA), the National
Institute of Child Health and Human Development (NICHD) and the
National Institute of Neurological Disorders and Stroke (NINDS)
encourage investigator-initiated research grant applications to
isolate, characterize and identify precursor cells required for normal
growth and repair of injured, aged, or diseased muscle. Goals include
determining factors responsible for migration, proliferation, and
differentiation of precursor cells following muscle injury or increased
exercise. This includes characterizing molecular controls responsible
for the quiescence of muscle satellite cells and determining metabolic
and motile properties of satellite cells while they are quiescent.
Researchers are encouraged to develop strategies using muscle satellite
and stem cells in therapies for human disease and enhanced repair of
muscle injury and as cellular vectors of genes.
Expiration Date: Saturday, October 26, 2002 NOFO Number: RFA-HD-02-023 Release Date: Monday, July 22, 2002 Notice Type: RFA
Pharmacological compounds have the potential to enhance functional recovery
in rehabilitation, especially when used in conjunction with behavioral and
physical therapy. This Request for Applications (RFA) supports studies
relevant to the treatment of neurological conditions such as stroke, brain
trauma, spinal cord injury, neurodevelopmental and neurodegenerative
disorders, infections, and neurosurgery. Applications in response to this
RFA must focus on rehabilitative strategies rather than the reduction of
acute pathology. They may include studies involving synaptic plasticity,
neurotransmitter interactions, neurotrophic mechanisms, pain or fatigue, or
any other neurological mechanisms that accelerate the recovery process,
enhance function or reduce disability. Studies in validated animal models
may be proposed, provided they include appropriate functional outcomes.
Pilot clinical trials in humans may also be considered.
Expiration Date: Friday, November 22, 2002 NOFO Number: RFA-NS-03-002 Release Date: Friday, July 19, 2002 Notice Type: RFA
Data from a survey from the Association of Neuroscience Departments and
Programs (2000) indicate that only 8% of tenure-track faculty are from
racial/ethnic minority populations. The NIH "Program of Action to
Address Health Disparities" recognizes that success in building an
effective biomedical research infrastructure, and our ability to
deliver research benefits to at-risk populations requires a commitment
to training and supporting scientists from diverse racial/ethnic
backgrounds.
Expiration Date: Wednesday, November 2, 2005 NOFO Number: PAS-02-129 Release Date: Thursday, July 18, 2002 Notice Type: PAS
With this Program Announcement, the National Institute of Neurological
Disorders and Stroke (NINDS) invites research grant applications (R01) that
address the development and treatment of dopamine-induced dyskinesias, a
major complication of current pharmacotherapy of Parkinson"s disease. The
purpose of this initiative is to 1) support the study of the pathophysiologic
basis of dopamine-induced dyskinesias, and 2) support the study of non-
dopaminergic pharmacologic agents for the treatment of dopamine-induced
dyskinesias.
Expiration Date: Saturday, July 30, 2005 NOFO Number: PAR-02-130 Release Date: Thursday, July 18, 2002 Notice Type: PAR
The National Institute of Neurological Disorders and Stroke (NINDS),
the National Institute on Deafness and Other Communication Disorders
(NIDCD) and the National Institute on Drug Abuse (NIDA) are committed
to expanding neuroscience research opportunities for faculty, students
and fellows at minority institutions. Data taken from the National
Academy of Sciences Report (2000) entitled "Addressing the Nation"s
Changing Needs for Biomedical and Behavioral Scientists" demonstrates
that the proportion of racial/ethnic minorities receiving scientific
graduate degrees is not representative of the general population.
Moreover, a survey from the Association of Neuroscience Departments and
Programs (2000) demonstrated that only 8% of tenure-track faculty were
minorities. To address this issue, the NINDS and NIDA Strategic Plans
on Minority Health Disparities and the NIDCD aim to enhance research
capacity building and training among minority institutions.
Expiration Date: Friday, December 2, 2005 NOFO Number: PA-02-127 Release Date: Wednesday, July 10, 2002 Notice Type: PA
A particular area of research is often invigorated by novel perspectives. In an
effort to advance research relevant to the mission of the National Institutes of
Health (NIH, which includes basic biomedical, clinical biomedical,
bioengineering, bioimaging, and behavioral research), the participating
Institutes and Centers solicit applications for the Mentored Quantitative
Research Career Development Award (K25). The K25 mechanism is meant to attract
to NIH-relevant research those investigators whose quantitative science and
engineering research has thus far not been focused primarily on questions of
health and disease. Examples of quantitative scientific and technical
backgrounds considered appropriate for this award include, but are not limited
to: mathematics, statistics, economics, computer science, imaging science,
informatics, physics, chemistry, and engineering.
Expiration Date: Friday, November 15, 2002 NOFO Number: RFA-TW-03-001 Release Date: Thursday, June 20, 2002 Notice Type: RFA
The purpose of this initiative is to stimulate investigator-initiated
research on the role of stigma in health, and on how to intervene to prevent
or mitigate its negative effects on the health and welfare of individuals,
groups and societies world-wide. Collaborative interdisciplinary
applications are particularly encouraged. The following Institutes and
Centers from the U.S. Department of Health and Human Services (DHHS): the
Health Research Services Administration (HRSA), the NIH including: the
Fogarty International Center (FIC), National Center on Minority Health and
Health Disparities (NCHMD), National Institute of Neurological Disorders and
Stroke (NINDS), National Human Genome Research Institute (NHGRI), National
Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institute of
Allergy and Infectious Diseases (NIAID), National Institute of Dental and
Craniofacial Research (NIDCR), National Institute of Drug Abuse (NIDA),
National Institute of Mental Health (NIMH), Office of AIDS Research, Office
of Behavioral and Social Science Research (OBSSR), Office of Research on
Women"s Health (ORWH), and the Canadian Institutes of Health Research (CIHR),
seek domestic and international applications which address stigma-related
issues, across a variety of global public health problems, among individuals
and in society.